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1. Introduction 
Notexin from the venom of Notechis scutatus 
scutatus is a basic protein with 119 amino acid 
residues and seven disulfide bridges which blocks 
neuromuscular transmission by interfering with the 
release of acetylcholine from the motor nerve 
terminals [ 1,2] . Notexin exhibits phospholipase 
activity and is highly homologous to phospholipase 
A from porcine pancreas and various snake venoms 
[3-51, raising the possibility that the neurotoxicity 
is catalytic in nature, involving the hydrolysis of 
a special phospholipid structure in the nerve 
terminal. Furthermore, it has recently been 
suggested that another presynaptic snake venom 
neurotoxin, /I-bungarotoxin, acts by inhibiting 
oxidative phosphorylation in the mitochondria of 
nerve terminals through a phospholipase A 
activity [6], 
The discovery that porcine pancreatic 
phospholipase AZ can be completely inactivated 
by the modification of a single histidine residue 
with p-bromophenacyl bromide [7] appeared to 
offer a means of assessing the role of phospholipase 
activity in the presynaptic blocking action of 
notexin. Notexin exhibited a 99.8% loss of both 
phospholipase A activity and lethal neurotoxicity 
upon treatment withp-bromophenacyl bromide. 
Ultraviolet difference spectroscopy and amino acid 
analysis showed that the inactivation was 
accompanied by the incorporation of 1 p- 
bromophenacyl residue and the disappearance of 
1 histidine residue per mole of protein. The 
modified residue was identified as histidine-48, 
72 
which corresponds to the histidine residue shown 
to be part of the catalytic site of the pancreatic 
enzyme. Calcium protects notexin against the modi- 
fication and changes the ultraviolet absorption 
spectrum of both the native and modified 
protein. Native and modified notexin bind calcium 
in a 1: 1 molar ratio at calcium concentrations 
ranging from 2 X lo-’ to 2 X 10-i M. At pH 
7.4 the dissociation constant of the native toxin- 
calcium complex is 1.4 X 10e4M and that of the 
modified toxin-calcium complex 2.5 X 10m2 M. 
2. Materials and methods 
Notexin was isolated as described previously [3]. 
Staphylococcal protease was a gift from Dr A.-C. 
Ryden. p-Bromophenacyl bromide was purchased 
from Fluka AC. All other reagents and materials 
were of the highest grade available and were used 
without further purification. 
Toxicity assays were performed by intravenous 
injection into the tail vein of white mice weighing 
between 25 and 30 g. Three to four mice were 
used at each dose level. The toxin concentration 
was determined spectrophotometrically using a 
predetermined extinction coefficient. 
Phospholipase A assays were performed by a 
slight modification of the titrimetric method of 
de Haas et al. [8]. Titrations were done with 
0.01 M NaOH on a TTT-1 Radiometer autotitrator 
at 25’C and pH 8.0. As substrate 2 ml of an 
aqueous emulsion of egg yolk was used in the 
presence of 2.7 X 10e3M solium deoxycholate and 
2 X 1 O-’ M calcium. 
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Modification withp-bromophenacyl bromide 
was done at 30°C at a molar reagent:protein ratio 
of 5: 1 in 0.1 M sodium cacodylate-HCl buffer 
(pH 6.0) containing 0.1 M NaCl [7] . The protein 
was dissolved in buffer at a concentration of 
7X lo-‘M(1 mg/ml),and25pl 1.4X 10m2M 
p-bromophenacyl bromide in acetone was added 
per mg of protein at 0 time. The kinetics of the 
modification in the presence and absence of 
calcium were studied by removing 1 ml aliquots 
at suitable times and acidifying them with 25 ~1 
glacial acetic acid to stop the reaction. After dialysis 
for 6 h against 1 litre 0.1 M acetic and 2 X 12 h 
against 1 litre portions of 0.43 M ammonium 
acetate the sample was applied to a column’of 
Bio-Rex 70 for separation and quantification of 
modified and native protein. 
Ion-exchange chromatography was performed 
on a 1 X 33 cm column of Bio-Rex 70 (-400 mesh) 
equilibrated with 0.43 M ammonium acetate. The 
sample was applied in 1 ml 0.43 M ammonium 
acetate and eluted at 9.3 ml per h with the same 
buffer. The runs were monitored with a Multiref 
901 differential refractometer (Optilab, Vbllingby, 
Sweden), and 2-ml fractions were collected. 
The areas of the peaks were estimated by 
triangulation. 
Amino acid analysis was done with a Durrum 
D-500 analyzer following hydrolysis for 24 h with 
6 N HCl at 110°C inthoroughly sealed evacuated 
tubes. 
Direct and difference spectra were recorded on 
a Beckman double-beam spectrophotometer using 
cuvettes of l-cm path length. Molar extinction 
coefficients were determined by amino acid 
analysis of samples of known absorbance. 
The number of p-bromophenacyl residues 
incorporated per mole of protein was determined 
by comparison of the molar difference extinction 
coefficient of modified vs. native protein with the 
molar extinction coefficient of the reagent. 
Determination of the dissociation constant of 
the native toxin-calcium and modified toxin-calcium 
complexes was performed by ultraviolet difference 
spectroscopy as described for porcine pancreatic 
phospholipase A2 [9]. The protein was dissolved 
at a concentration of 5 X lo-’ M in 0.1 M sodium 
cacodylate-HCl (pH 7.4) containing 0.1 M NaCl. 
Calcium ion stock solutions with a concentration 
of about 25 times the estimated dissociation 
constant were added to the sample cell and an 
equal volume of buffer to the reference cell. A 
double reciprocal plot of PA vs. [Ca”] gave a 
straight line from which the maximal 
absorbance (Mm,) and the molar difference 
extinction coefficient were calculated. The 
dissociation constant and the number of 
binding sites were determined by a Scatchard 
plot of V,,z+/[Ca”] vs. VCa2+ where VCa2* = AA/ 
aAm, [loI. 
Reduction and S-carboxymethylation of 
modified notexin was performed in 6 M 
guanidine hydrochloride buffered at pH 8.3 with 
0.86 M Tris-HCl and containing 0.3% EDTA. To 
0.6 /._mlol of protein in 3 ml buffer 6.5 mg 
dithioerythritol was added, corresponding to a 
lo-fold excess of reagent over disulfide. After 4 h 
84 pmol (17.5 mg) sodium iodoacetate was added 
in 1 ml distilled water. After 15 min the sample 
was dialyzed for 3 X 12 h against 1 litre portions 
of distilled water. 
Identification of the modified residue was 
accomplished by digesting the reduced and S- 
carboxymethylated modified protein with 
staphylococcal protease and isolating the peptide 
containing a p-bromophenacyl residue by gel 
filtration and column electrophoresis [3]. Spectra 
were run on the three fractions obtained from the 
digest by gel filtration on a 1 X 142 cm column 
of Sephadex G-25, and the fraction showing an 
adsorption maximum at 262 nm (Max for the 
reagent) was submitted to column electrophoresis 
for 22 h at 1000 V at pH 5.0. 
The susceptibility of the native and modified 
protein to proteolytic digestion was studied by 
incubation of protein (10 mg/ml) with trypsin 
(0.37 mg/ml) at 37’C in 0.1 M N-ethylmorpholine 
acetate buffer (pH 7.5) containing 5 X 1 0W3 M 
calcium. After 1 h the digestion was terminated by 
addition of acetic acid, and the digests were 
lyophilized. Half of each digest was examined by 
paper electrophoresis at pH 3.5 for 1 h at 3000 V, 
and the remaining half was subjected to performic 
acid oxidation [ 1 l] and then lyophilized and 
examined by paper electrophoresis at pH 6.5 for 
1 h at 3000 V. 
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3. Results 
As shown in fig. 1 modified notexin can be 
completely separated from native toxin by elution 
chromatography on Bio-Rex 70. The properties 
of the native and modified toxin are summarized 
in table 1. 
Fig.2 is a semilogarithmic plot illustrating the 
first-order dissappearance of native notexin upon 
incubation with p-bromophenacyl bromide. The 
presence of 1 mM calcium increases the half-time 
from 187 min to 442 min, suggesting that calcium 
binds to the same site as the reagent. 
The binding of calcium to both native and 
modified notexin changes the protein absorption 
spectrum. The ultraviolet difference spectrum 
of native notexin is very similar to that of porcine 
pancreatic phospholipase AZ, i.e., there is a strong 
band at 242 nm and two smaller bands at 282 and 
288 nm 191. However, in contrast to modified 
pancreatic phospholipase [ 121, modified notexin 
is still able to bind calcium. The ultraviolet difference 
spectrum of modified notexin is characterized by a 
well extending from 242 to 280 nm, the minimum 
of which shifts from 250 to 260 nm as the calcium 
r 
fh 1 2 
Fig.1. Separation of native (Peak 1) and modified (Peak 
2) notexin by elution chromatography on a 1 X 33 cm 
column of Bio-Rex 70 in 0.43 M ammonium acetate as 
described in Methods. The breakthrough peak at 19 ml 
is due to residual buffer salts and contains no protein. 
?I::,:::: 
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Fig.2. Disappearance of native notexin as a function of 
time of incubation with a 5: 1 molar cxccss of IJ- bromo- 
phenacyl bromide as described in Methods. 
(o) No calcium in incubation mixture. 
(x) 1 mM calcium. 
concentration is increased from 6 X 10m4 to 
1 X 10-l M. The small bands at 282 and 288 run are 
still present. 
In order to determine whether the loss of 
lethal neurotoxicity accompanying the modification 
was the result of an enhanced susceptibility to 
proteolytic degradation, native and modified 
notexin were incubated with trypsin. No difference 
could be detected between the digests upon 
examination by high voltage paper electrophoresis 
either before or after performic acid oxidation. The 
digest of the native protein showed 20% residual 
phospholipase activity after the treatment with 
trypsin. 
4. Discussion 
Although the loss of lethal neurotoxicity seems 
to parallel the loss of phospholipase A activity, we 
feel that it would be premature to conclude 
definitely that the phospholipase activity is 
essential to the presynaptic blocking action of 
notexin. Preliminary experiments in isolated 
nerve-muscle preparations seem to indicate that 
the modified toxin has a residual in vitro activity 
exceeding that expected on the basis of the 0.2% 
residual phospholipase activity [ 13 ] . Unfortunately 
no quantitative data on the in vitro activity are 
available at present. Furthermore, notexin exhibits 
a direct dystrophic action on striated muscle 
74 
Volume 61. number 1 FEBS LETTERS January 1976 
Table 1 
Properties of native and p-bromophenacyl bromide-modified notexin 
Native Modified 
Number of histidine 
residues per mole of 
protein 
3 2 
Molar extinction 
coefficient 
Number of p-bromo- 
phenacyl residues 
per mole of protein 
Modified residue 
27 600 45 500 
(278 nm) (276 nm) 
0 1.0a 
850 
His-48b 
1.8 Specific phospho- 
lipase activity 
bequiv OH per min 
per mg protein) 
LD,, (mg per kg mouse) 
Molar difference extinction 
coefficient upon 
calcium bindingC 
0.025 10 
1200 1200 
(242 nm) (260 nm) 
Number of calcium 
binding sitesC 
1.1 1.0 
Protein-calcium 
dissociation constant (M)’ 
1.4 x 10-4 2.5 x 1o-2 
a The molar difference extinction coefficient of modified vs. native 
notexin was 18 500 with a maximum at 271 nm. The extinction 
coefficient of the reagent was 17 600 with a maximum at 262 nm 
(determined in methanol). 
b Based on the isolation of a peptide corresponding in amino acid 
composition to residues 41-54 in the notexin sequence xcept for 
the lack of histidine. The molar extinction coefficient was 19 800 
at 262 nm, although the peptide contained only one aromatic residue, 
Tyr-52. 
c pH 7.4. 
cells [2,14] which is probably related to the 
neurotoxicity, and this function is not greatly 
diminished after modification with p-bromophenacyl 
bromide [ 151. The loss of lethality attending the 
chemical modification might reflect a loss of 
specificity, possibly as a result of the impaired 
ability to bind calcium. The injected modified 
notexin might thus be diluted out by adsorption 
to other membranes and never reach the nerve 
terminal. 
The slight residual phospholipase activity of the 
modified toxin is puzzling. It cannot be attributed to 
contamination by native notexin since it is not 
diminished by re-chromatography on Bio-Rex 70 
and furthermore, the modification seems to be 
irreversible. 
The phospholipase activity of notexin may be 
essential to its presynaptic blocking action, but 
the question of which structural features make this 
particular phospholipase highly neurotoxic whereas 
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the vast majority of phospholipases are non- or 
poorly toxic remains to be answered. 
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